These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10807044)

  • 21. Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes.
    Shames BD; Selzman CH; Meldrum DR; Pulido EJ; Barton HA; Meng X; Harken AH; McIntyre RC
    Shock; 1998 Dec; 10(6):389-94. PubMed ID: 9872676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.
    Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M
    Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
    Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
    Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells.
    Byrd VM; Ballard DW; Miller GG; Thomas JW
    J Immunol; 1999 May; 162(10):5853-9. PubMed ID: 10229820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of tolerance to hemorrhagic or endotoxic shock involves activation of NF-kappaB.
    Kramer AA; Salhab KF; Shafii AE; Norman J; Carey LC; Mendez C
    J Surg Res; 1999 May; 83(2):89-94. PubMed ID: 10329100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation.
    Zwacka RM; Zhang Y; Zhou W; Halldorson J; Engelhardt JF
    Hepatology; 1998 Oct; 28(4):1022-30. PubMed ID: 9755239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1.
    Azuma M; Motegi K; Aota K; Yamashita T; Yoshida H; Sato M
    Exp Cell Res; 1999 Jul; 250(1):213-22. PubMed ID: 10388535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nuclear factor--kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease.
    Pamukcu B; Lip GY; Shantsila E
    Thromb Res; 2011 Aug; 128(2):117-23. PubMed ID: 21636112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. hCLOCK induction by hypoxia promotes inflammatory responses by activating the NF‑κB pathway.
    Tang X; Guo D; Lin C; Shi Z; Qian R; Fu W; Liu J; Li X; Fan L
    Mol Med Rep; 2017 Mar; 15(3):1401-1406. PubMed ID: 28098888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NF-κB as an Inducible Regulator of Inflammation in the Central Nervous System.
    Anilkumar S; Wright-Jin E
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F1: a magic bullet for atherosclerosis?
    Dong C; Goldschmidt-Clermont PJ
    Circulation; 2002 Nov; 106(21):2640-1. PubMed ID: 12438285
    [No Abstract]   [Full Text] [Related]  

  • 32. Interactions between NFkappaB and its inhibitor ikappaB: biophysical characterization of a NFkappaB/ikappaB-alpha complex.
    Li T; Narhi LO; Wen J; Philo JS; Sitney K; Inoue J; Yamamoto T; Arakawa T
    J Protein Chem; 1998 Nov; 17(8):757-63. PubMed ID: 9988522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signaling Crosstalk Mechanisms That May Fine-Tune Pathogen-Responsive NFκB.
    Adelaja A; Hoffmann A
    Front Immunol; 2019; 10():433. PubMed ID: 31312197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis.
    Mozzato-Chamay N; Corbett EL; Bailey RL; Mabey DC; Raynes J; Conway DJ
    Genes Immun; 2001 May; 2(3):153-5. PubMed ID: 11426324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of experimental lung inflammation.
    Lentsch AB; Ward PA
    Respir Physiol; 2001 Oct; 128(1):17-22. PubMed ID: 11535258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NFkappaB-dependent signaling pathways.
    Li X; Stark GR
    Exp Hematol; 2002 Apr; 30(4):285-96. PubMed ID: 11937262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NFkappaB is a Key Player in the Crosstalk between Inflammation and Cardiovascular Diseases.
    Fiordelisi A; Iaccarino G; Morisco C; Coscioni E; Sorriento D
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30935055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocyte Chemotactic Protein-Induced Protein 1 (MCPIP-1): A Key Player of Host Defense and Immune Regulation.
    Jin Z; Zheng E; Sareli C; Kolattukudy PE; Niu J
    Front Immunol; 2021; 12():727861. PubMed ID: 34659213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taurine is involved in oxidation of IkappaB alpha at Met45: N-halogenated taurine and anti-inflammatory action.
    Miyamoto Y; Kanayama A; Inoue J; Konishi YS; Shimizu M
    Adv Exp Med Biol; 2003; 526():373-80. PubMed ID: 12908622
    [No Abstract]   [Full Text] [Related]  

  • 40. Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin.
    Vlahopoulos SA
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.